Sullivan is professor of health economics and policy and former dean of pharmacy at the University of Washington. Hansen is professor of health economics and policy and chair of the Department of ...

You can talk to the chatbot like it's a friendly acquaintance, and it'll help you get a lot done. Amanda Smith is a freelance journalist and writer. She reports on culture, society, human interest and ...

Amgen Inc. (AMGN) reported strong Q4 2025 results and provided full-year 2026 guidance that was above Street expectations. The company is managing losses of exclusivity on several large products quite ...

Mr. Shirky, a vice provost at New York University, has been helping faculty members and students adapt to digital tools since 2015. Back in 2023, when ChatGPT was still new, a professor friend had a ...

For decades, the United States has led the world in developing groundbreaking medications that allow patients to live longer and healthier lives. Despite these contributions, American families pay ...

Americans will soon be able buy some prescription drugs at discounted cash prices through TrumpRx, a new self-pay website launching Thursday as part of President Donald Trump’s broader push to lower ...

Wegovy might be getting more competition soon. During the first half of 2025, Wegovy and Zepbound, two weight loss drugs, ranked among the top 10 best-selling medicines worldwide. And given current ...

Amgen AMGN reported fourth-quarter 2025 adjusted earnings of $5.29 per share, which beat the Zacks Consensus Estimate of $4.76 per share. Earnings were relatively flat year over year as higher ...

The Trump administration launched a new website, TrumpRx, to offer Americans discounts on prescription drugs. The program aims to lower drug costs through "most-favored-nation-pricing" deals with ...

Amgen is hopeful that Phase III data will cement the validity of its recently approved widened label for cholesterol-lowering drug Repatha (evolocumab). In August 2025, the US Food and Drug ...

Jon has been an author at Android Police since 2021. He primarily writes features and editorials covering the latest Android news, but occasionally reviews hardware and Android apps. His favorite ...